Objective This study explores the clinical characteristics of patients with diabetes with severe
covid-19, and the association of diabetes with survival duration in patients with severe covid …

Aims: The 2019 novel coronavirus disease (COVID-19) emerged in Wuhan, China, and was
characterized as a pandemic by the World Health Organization. Diabetes is an established …

OBJECTIVE Diabetes is common in COVID-19 patients and associated with unfavorable
outcomes. We aimed to describe the characteristics and outcomes and to analyze the risk …

Abstract Background Coronavirus disease 2019 (COVID-19) is an emerging infectious
disease that first appeared in Wuhan, China, and quickly spread throughout the world. We …

Aims To describe characteristics of COVID-19 patients with type 2 diabetes and to analyze
risk factors for severity. Methods Demographics, comorbidities, symptoms, laboratory …

Abstract Background Coronavirus disease 2019 (COVID‐19) is a rapidly progressing
pandemic, with four million confirmed cases and 280 000 deaths at the time of writing. Some …

Aim To describe the epidemiological and clinical characteristics along with outcomes of
hospitalized Coronavirus Disease 2019 (COVID-19) patients with and without diabetes …

Background COVID-19 has a highly variable clinical presentation, ranging from
asymptomatic to severe respiratory symptoms and death. Diabetes seems to be one of the …

Background Many studies on COVID-19 have reported diabetes to be associated with
severe disease and mortality, however, the data is conflicting. The objectives of this meta …

Aims This study evaluated the impact of previous glycemic control and in-hospital use of
antidiabetic/antihypertensive drugs on the prognosis of COVID-19 patients with diabetes …